Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASCI.L Regulatory News (ASCI)

  • There is currently no data for ASCI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

14 Sep 2021 07:00

RNS Number : 6094L
Aberdeen Smaller Co's Inc Tst PLC
14 September 2021
 

Aberdeen Smaller Companies Income Trust PLC

Half Yearly Financial Report for the six months to 30 June 2021

 

 

OBJECTIVE

The objective of the Company is to provide a high and growing dividend and capital growth from a portfolio invested principally in the ordinary shares of smaller UK companies and UK fixed income securities.

 

BENCHMARK

Numis Smaller Companies ex Investment Trusts Index - effective from 1 January 2020;

FTSE Small Cap ex Investment Trusts Index (total return) - up to 31 December 2019

 

MANAGEMENT

The Company's alternative investment fund manager is Aberdeen Standard Fund Managers Limited ("ASFML" or "the Manager") (authorised and regulated by the Financial Conduct Authority). The Company's portfolio is managed on a day-to-day basis by Aberdeen Asset Managers Limited ("AAML" or "the Investment Manager") by way of a delegation agreement in place between ASFML and AAML.

 

 

HIGHLIGHTS

 

Net asset value total return {A}

Numis Smaller Companies ex Inv Trust Index

Share price total return {A}

Six months ended 30 June 2021

Six months ended 30 June 2021

Six months ended 30 June 2021

+20.1%

+17.4%

+9.4%

Year ended 31 December 2020: -4.1%

Year ended 31 December 2020: -4.3%

Year ended 31 December 2020: -5.1%

Earnings per Ordinary share (revenue)

Discount to net asset value {A}

Net gearing {A}

Six months ended 30 June 2021

As at 30 June 2021

As at 30 June 2021

4.14p

17.9%

2.5%

Six months ended 30 June 2020: 2.03p

As at 31 December 2020: 10.3%

As at 31 December 2020: 7.0%

{A} Considered to be an Alternative Performance Measure. Further details can be found below.

 

 

30 June2021

31 December 2020

%change

Shareholders' funds (£'000)

91,528

77,144

+18.6

Net asset value per Ordinary share

413.97p

348.91p

+18.6

Share price (mid-market)

340.00p

313.00p

+8.6

Discount to net asset value per Ordinary share{A}

17.9%

10.3%

Net gearing{A}

2.5%

7.0%

Ongoing charges ratio{A}

1.25%

1.35%

{A} Considered to be an Alternative Performance Measure. Further details can be found below.

 

 

PERFORMANCE (TOTAL RETURN)

 

 Six months ended

 1 year ended

 3 years ended

 5 years ended

 30 June 2021

 30 June 2021

 30 June 2021

 30 June 2021

Share price{A}

+9.4%

+32.6%

+25.5%

+117.5%

Net asset value per Ordinary share{A}

+20.1%

+38.6%

+30.1%

+103.0%

Composite benchmark{B}

+17.4%

+49.8%

+13.9%

+55.5%

{A} Considered to be an Alternative Performance Measure. Further details can be found below.

{B} Comprises the Numis Smaller Companies (exc Inv Trusts) from 1 January 2020 and the FTSE SmallCap Index (exc Inv Trusts) up to 31 December 2019.

Source: ASFML, Lipper & Morningstar.

 

 

CHAIRMAN'S STATEMENT

Performance

I am pleased to report that your Company has delivered out-performance relative to its benchmark, the Numis Smaller Companies ex Investment Trusts Index in the six month period to the end of June 2021, with a net asset value ("NAV") total return of +20.1% versus a benchmark return of +17.4%.

 

The Company still also continues to display strong out-performance over 3 and 5 year periods. Over 1 year, however, the Company has under-performed its benchmark. This was driven largely by the sharp market rotation we saw, particularly during the months of November 2020 through to February 2021, which didn't favour the Manager's focus on long term quality and growth characteristics.

 

The Company's share price over the period has increased by 8.6%, and since the half year end has continued to climb, illustrating a return of investor optimism towards UK equities, particularly since March 2021, when signs of economic recovery became evident and the UK demonstrated a leading position in the COVID-19 vaccine rollout.

 

We are disappointed to see, however, that the Company's discount has widened, from -10.3% at the start of the year, to -17.9%, at the period end. This is something that the Board continue to monitor.

 

Company Gearing and Debt

The Company renewed its £5million revolving credit facility for a 1 year period in April 2021 and also has a 5 year £5million fixed rate loan facility expiring in 2023, of which a total of £7million is currently drawn down. Portfolio gearing stood at 2.5% at the end of June 2021, compared with 7.0% at the end of December 2020. The lower gearing percentage was not as a result of a reduction in the amount drawn down under the facility; it was reflective of a temporarily larger cash position held by the Manager at the period end, which had arisen due to the timing of trade settlements.

 

Dividend

For the first and second quarters of this year, the Board announced dividends of 2.15p each per Ordinary share (2020 - 2.06p each), an increase on last year's equivalent figures of 4.4%. This compares to an increase in the CPI for the first six months of this year of 1.9%.

 

Following a period of dividend cuts and cancellations in 2020, the companies in which the Company invests have predominantly returned to paying dividends in 2021, with some having boosted recent dividends to compensate for the lack of payments made last year. More information on this can be found in the Investment Manager's review.

 

We've been pleased with the recovery in portfolio income since the onset of the pandemic, and are well on the pathway to 2019 levels. The dividend growth outlook across the holdings is being supported by the earnings growth that companies are demonstrating. The Company's remaining revenue reserves, are also available to be utilised, as necessary, to support resilient income to our shareholders.

 

In the meantime, the Company continues to maintain a good level of revenue reserves which has demonstrated that, in times of lower income levels, the Company can continue to provide an attractive return to shareholders.

 

The Manager

In July 2021, Standard Life Aberdeen plc changed its name to abrdn plc as part of a rebranding exercise. We expect the Company's Manager, Investment Manager and Company Secretary (Aberdeen Standard Fund Managers Limited, Aberdeen Asset Managers Limited and Aberdeen Asset Management PLC respectively) to also be renamed in the coming months.

 

Company Change of Name

The Board is supportive of the Manager's rebranding exercise and is currently considering options for the Company to change its name, to align itself to the new brand. We will keep shareholders informed via the Company's website and Stock Exchange announcements.

 

Board & AGM

During the first half of the year, Barry Rose retired from the Board and after a formal search process, Christopher Metcalfe was appointed as an independent Non-Executive Director in his place. It has been a privilege to experience Barry's acute forensic questioning and thinking and we believe that Christopher's extensive investment experience will be equally valuable.

 

Disappointingly, we were unable once again this year to welcome shareholders at our AGM, due to COVID-19. Your Manager's presentation, which would have been delivered at the meeting, has been uploaded to the Company's website, www.aberdeensmallercompanies.co.uk. I do recommend that you watch it.

 

Outlook

Your Manager and the Board view the outlook for the remainder of the Company's financial year with optimism. With smaller companies and mid-cap companies having a tendency to be at the forefront of market recovery, we have seen the companies in which the Company invests strongly driving earnings upgrades.

 

The Company has also seen good performance in recent months, and the value rally initiated by the vaccine announcement in November 2020, which ran through to February 2021, looks to be largely behind us.

 

Your Manager continues to engage with companies in order to identify the quality growth momentum businesses it likes to invest in, and we look forward to the next reporting period with confidence.

 

Balance sheets in the companies in which we invest are strong and dividend growth is now coming through, which we are hopeful will ensure a more steady level of income growth across the portfolio in the future.

 

 

Robert Lister,

Chairman

13 September 2021

 

 

OTHER MATTERS

 

Principal Risks and Uncertainties

There are a number of risks which, if realised, could have a material adverse effect on the Company and its financial condition, performance and prospects. The Board has identified the principal risks and uncertainties facing the Company together with a description of the mitigating actions it has taken. These can be summarised under the following headings:

 

- Investment and Market

- Investment Portfolio Management

- Gearing

- Income and Dividend

- Operational

 

Details of these risks are provided in detail on pages 21 to 23 of the 2020 Annual Report.

 

In addition to these risks, there are also a large number of international political and economic uncertainties which could have an impact on the performance of global markets. The outbreak of the COVID-19 virus has resulted in business disruption and stockmarket volatility across the world. The extent of the effect of the virus, including its long term impact, remains uncertain. The Manager has undertaken a detailed review of the investee companies in the Company's portfolio to assess the impact of COVID-19 on their operations such as employee absence, reduced demand, reduced turnover and supply chain breakdowns and will continue to review carefully the composition of the Company's portfolio and will be pro-active where necessary. In addition the Manager implemented extensive business continuity procedures and contingency arrangements to ensure that is is to continue to service its clients, including investment trusts.

 

The Board will continue to monitor developments as they occur.

 

In all other respects, the Company's principal risks and uncertainties have not changed materially since the year end, nor are they expected to change in the second half of the financial year ended 31 December 2021.

 

Going Concern

In accordance with the Financial Reporting Council's Guidance on Risk Management, Internal Control and Related Financial and Business Reporting issued in September 2014, the Directors have undertaken a rigorous review and consider both that there are no material uncertainties and that the adoption of the going concern basis of accounting is appropriate. The Company's assets consist principally of equity shares in companies listed on the London Stock Exchange and in most circumstances are realisable within a short timescale.

 

The Directors have a reasonable expectation that the Company has adequate financial resources to continue in operational existence for the foreseeable future and at least twelve months from the date of approval of this Half Yearly Report. Given that the Company's portfolio comprises primarily "Level One" assets (listed on a recognisable exchange and realisable within a short timescale), and the Company's relatively low level of gearing, the Directors believe that adopting a going concern basis of accounting remains appropriate.

 

Directors' Responsibility Statement

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

 

- the condensed set of Financial Statements has been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting'

- the Interim Board Report includes a fair review of the information required by rule 4.2.7R of the Disclosure Guidance and Transparency Rules (being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of Financial Statements and a description of the principal risks and uncertainties for the remaining six months of the financial year)

- the Interim Board Report includes a fair review of the information required by 4.2.8R (being related party transactions that have taken place during the first six months of the financial year and that have materially affected the financial position of the Company during that period; and any changes in the related party transactions described in the last Annual Report that could do so).

 

The Half Yearly Financial Report for the six months to 30 June 2021 comprises the Interim Board Report and a condensed set of financial statements.

 

 

For and on behalf of the Board

Robert Lister,

Chairman

13 September 2021

 

 

INVESTMENT MANAGER'S REVIEW

 

The Company delivered a NAV total return of 20.1%, outperforming the Numis Smaller Companies ex-Investment Trusts Index return of 17.4% for the six month period to 30 June 2021. We were pleased to see the stronger performance in the second quarter reverse the underperformance in the first quarter; this delivered outperformance against the benchmark over the half year period.

 

Equity markets

The global economy started to recover from the effects of the pandemic in the first half of 2021. Despite a rise in COVID-19 cases in India and renewed outbreaks in many other geographies, vaccination programmes across the world gathered pace, leading to the progressive scaling back of restrictions. The recovery has been further fuelled by very supportive monetary and fiscal policy. Huge stimulus packages have continued to be announced, central banks have kept rates on hold and further support has been provided through bond buying programmes.

 

The recovery has been evident in the improvement in economic data and rise in corporate profitability. Despite economic growth falling by 1.5% in the first quarter, primarily due to lockdowns, the Bank of England raised its 2021 GDP growth forecast to 7.25% and noted that rising inflation numbers were most likely temporary. The earnings season saw investor focus shift to corporate earnings announcements, which were generally better than expected. While some travel related areas remain challenged, the acceleration in worldwide vaccine rollouts has allowed businesses to reopen and the economic recovery to broaden-out. UK markets in general have performed less well than most other markets, particularly the technology heavy Nasdaq index in the USA, as well as most European and Far East markets, where COVID-19 was tackled in a more robust fashion, and economies made a quicker recovery. Mergers & Acquisition activity continues to feature heavily in the UK market: this is driven by private equity funds and opportunist buyers taking advantage of the valuation-gap versus other markets, as well as the improving prospects of many businesses in a period of economic recovery.

 

The new issues market continues to be buoyant. As smaller companies investors, it has been pleasing to see the UK market hosting vibrant new growth businesses. We have enjoyed meeting prospective listed businesses but have remained selective and true to our Quality Growth and Momentum (QGM) investment process, with an income bias. We did not take part in any IPOs during the period as we were not comfortable that any provided both the quality growth aspects and the prospect of a growing dividend in the near term. More recently, we took part in the IPO of Seraphine, the maternity wear specialist, which we expect to yield around 1% and grow the dividend in line with expected earnings.

 

Performance

The NAV portfolio return for the Company for the six month period to 30 June 2021 was 20.1%, versus a benchmark return of 17.4%.

 

We have always been clear that the portfolio is positioned to deliver outperformance over the cycle and that there will be periods when we will underperform. The team has run the QGM investment process for over 20 years and, over that time, has seen that, during the periods of sharp recovery that typically follow a crisis in the market, our strategy temporarily underperforms. This is usually due to investors focusing on companies that have been particularly hard-hit during that downturn and these stocks do not normally meet our investment criteria.

 

A recovery rally is one of the most challenging environments for the relative performance of our investment process. Thankfully they occur only rarely and typically during rising markets, which generally favour smaller companies. In these environments our absolute performance remains attractive for investors; this was seen in Q1 2021, whilst the Company's performance might lag relative to benchmark. We are long-term investors and do not consider it appropriate to switch into cyclical recovery stocks for a short period. We prefer to stick to our process in all macro environments. This is evidenced by the contrast in the Company's performance between Q1 and Q2.

 

The first quarter was characterised by underperformance relative to the benchmark, given the strong value rally that we saw in January and February. It favoured cyclical recovery stocks and produced a challenging environment for our QGM focus.

 

In the second quarter we strongly outperformed the benchmark, with reporting season driving a market focus back onto company fundamentals and less on macro factors; reporting season showed strong and resilient earnings growth profiles across the portfolio, supporting earnings upgrades for many holdings.

 

Over the first half of the year, this mixture of two very different market periods has delivered outperformance that we are pleased with.

 

Asset Managers Liontrust and Tatton Asset Management were top contributors in the period with both companies reporting good growth (both in terms of Assets under Management ("AUM") and revenue). It was impressive to see Liontrust grow AUM aggressively against the backdrop of the pandemic, thanks to net inflows, positive performance and bedding in its recent acquisition of Architas. The business is highly cash generative and ended the year with substantial cash on the balance sheet. The full year dividend came in materially ahead of estimates, leading to a 42% increase in the full year pay-out. Liontrust will not continue to build cash on the balance sheet without clear purpose and will likely distribute in line with earnings. Management have delivered exceptional growth and there is still much to be optimistic about. There is opportunity across the fund range with continuing growth from flows and performance, and potential in recent acquisitions; set against compelling market dynamics.

 

The discretionary fund manager Tatton Asset Management is a similar story of momentum in flows, alongside good performance. Management navigated challenges posed by COVID-19 successfully and the final results showed impressive growth and strong operating margins. Funds under Management ("FUM") is growing very strongly and management gave the market an idea of their ambition by increasing their target for FUM materially from the current £9billion to £15billion over the next three years. The outlook for this business is attractive, with scope to double its size in the medium term and build on already high margins.

 

DiscoverIE was also a positive contributor in the period. The business has evolved from a distributor of electronic components to an international designer, manufacturer and supplier of customised, differentiated electronics. The strategy is to focus on generating organic growth in four target markets that are underpinned by structural shifts; namely Renewable Energy, Transportation, Industrial & Connectivity and Medical. Such focus on markets with long term thematic growth drivers is key to growth and reduces cyclicality. Organic growth is supplemented by acquisitions to broaden the product portfolio and geographical reach. We had plenty of evidence that DiscoverIE could outperform in an upcycle and its 2021 results illustrated that the business model is equally effective in a downturn. This gave the market confidence in the strength and resilience of the model and management execution. DiscoverIE issued an impressive full year trading update evidencing strong momentum, impressive cash generation and a positive outlook. The company also enhanced its Environmental, Social and Governance ("ESG") credentials by targeting a 50% reduction in carbon emissions over five years through a combination of: buying electricity from renewable sources where possible; implementing energy reduction measures; and installing renewable energy electricity sources on site. We continue to believe in the growth prospects and its target markets, particularly renewables given the increasing desire to switch to more sustainable energy sources. The strength of the end markets and order book should sustain the momentum, together with a healthy pipeline of acquisitions and the balance sheet firepower to match.

 

Morgan Sindall added value with profits ahead of expectations and upgraded earnings guidance for the year. The UK construction business is benefiting from structural growth in infrastructure; this is driven by increased investment and increased demand to help companies adapt offices to future ways of working. We remain confident in the growth potential on offer alongside the attractive approximate 4.2% yield.

 

Telecom Plus is a UK based multi-utility supplier. Trading as 'Utility Warehouse' it supplies gas, electricity, landline, broadband and mobile services to residences and businesses. Telecom Plus was a detractor from performance in the period, given home visits are the primary recruitment method and COVID-19 restrictions held back progress. Upon the full lifting of restrictions the business could see a material boost given the societal changes that are occurring. In particular, the shift to flexi/home-working is an ideal scenario for the company as it will provide more opportunity for partners to build their businesses; and customers will be more focused on their home services. In addition, the changes to the energy market mean that Telecom Plus can be very competitive on price. Furthermore, Ofgem is consulting on proposals to limit the level of consumer credit balances to ensure that those paying by direct debit do not overpay, which Ofgem estimates could result in cash being returned to customers if introduced in 2022. This could severely impact the business models of many of the company's competitors. The restrictions have been a headwind but investors have been paid to wait for the growth given the c.4.5% yield.

 

Games Workshop ("Games") is the designer, manufacturer and distributor of the two most popular miniature war games in the world, Warhammer 40k and Age of Sigmar. It's unusual that Games appears as a detractor to performance for the portfolio. Long-term, the company has been a strong positive contributor, and provides attractive and growing income. The shares climbed to an all-time high in the prior period, following a number of positive updates and despite COVID-19 disruption. The shares then drifted in the value rally at the beginning of the year. We were encouraged by the trading update in May 2021 which demonstrated another period of strong performance with profits ahead of expectations, despite currency headwinds and supply chain bottlenecks. The company's dividend policy is to return 'truly surplus capital'. To do this, the board of Games review the cash level regularly and return funds in excess of the level necessary for investment, running a sensible buffer so that the company does not require any bank borrowings. The board of Games announced a 50p dividend on the back of strong cash generation. Post COVID-19 the story has accelerated and management are investing for growth by expanding manufacturing and distribution capacity both in the UK and the USA. The outlook for the company is strong with a compelling product line-up and a healthy pipeline of licenced products to be released over the next few months. We still have strong conviction in the story and view Games as an asset of rare quality with standout returns and profitability metrics.

 

Assura owns primary healthcare properties in the UK comprising local GP surgeries, and larger primary care centres. The portfolio is split across a variety of sizes and locations. Assura's rental income is underpinned by a strong covenant, with the UK government (NHS) indirectly funding 84% of rental income. Assura invests in purpose-built, modern facilities let to primary care providers, easing the burden of national health requirements on hospitals and other advanced facilities. The NHS has made this central to its policy, creating a stable operating environment with steady demand and growing interest from both occupiers and investors. Assura was a detractor from performance given that the fears around the challenges presented by lockdowns meant surgeries had to operate on a remote basis. The property stocks have also lagged the recovery trade; however, the business has been resilient and has continued to receive rents in line with usual patterns. A solid cash flow and balance sheet also allowed continued expansion. Assura released strong FY 2021 results in May 2021 despite the adverse market conditions and the portfolio remains in a healthy position with 100% rent received during the financial year. We maintain that primary care remains a focus area for the NHS in order to facilitate both cost savings and improved patient outcomes, and we expect demand for modern, fit-for-purpose medical buildings to remain well supported. Assura's scale means there are greater avenues to growth and, given the challenges facing healthcare due to COVID-19, the company is well placed to support this.

 

Portfolio activity

As ever, our QGM with an income bias investment process has driven stock selection. During the first half of 2021 we added new positions in Mortgage Advice Bureau, CMC Markets, Synthomer and Robert Walters and exited positions in 4imprint and James Fisher.

 

Mortgage Advice Bureau is one of the UK's leading consumer intermediary brands and specialist appointed representative networks for mortgage intermediaries. The fast growing platform model allows customers to choose how and when they want to research, receive advice and transact. Technology is at the heart of both face-to-face and telephone advice: helping to provide greater speed, ease, and convenience; and, by doing so, delivering an increasingly more compelling customer proposition. It has demonstrated resilience in poor market environments since flotation in 2014; and we believe the momentum is set to build sharply while it converts a strong pipeline of advisers and when a number of long standing technology initiatives come to fruition. Management's lead generation tool, network management and adviser productivity agendas have the potential to be transformational to market share gains. The shares yield 2.8% with a strong dividend growth forecast. Management targets a pay-out ratio of 75% of adjusted earnings. The company's capital distribution capacity is underpinned by strong cash conversion and significant and growing capital surplus to regulatory requirements.

 

Synthomer is a specialist chemical company and one of the world's leading suppliers of aqueous polymers. It produces innovative formulations to support customers in a range of industries: from construction through paints and coatings, to healthcare. Synthomer works closely with its customers and targets a number one or two position in its core markets. Management's understanding of customer product and process requirements combined with their technology and process know-how are the key to the company's success. The strategy is to establish Synthomer as a growing global speciality chemical business through both organic growth (supported by investment in innovation) and inorganic growth. This high quality business offers strong earnings growth and strong cash returns to support the dividend yield of approximately 3%.

 

CMC Markets is primarily a provider of leveraged financial products (contracts for difference ("CFDs") and spread betting) to the retail market; other revenue streams come from stockbroking and white label contracts. There is a focus on diversifying the business beyond the leveraged product offering. Management recently announced they would launch a share dealing platform in the UK, to further diversify, and their ambitions are significant. Management have an unwavering strategic focus on high quality clients and we have seen record trading performance in the first half of the year. Profitability has been driven by increased client trading in the period as a result of higher market volatility and an increased client base. The company continues to deliver on strategic initiatives and maintain a healthy pipeline of projects that create new revenue streams through further product, channel and geographic diversification. These initiatives are all supported by technology and, through wider application, they can extend the offer and deliver further profitable growth. The CEO owns 60% of the company and is well aligned with investors. The shares yield approximately 4% and the dividend policy is to pay out 50% of profit after tax. After the period-end there were downgrades to earnings due to reduced client activity over July and August. Management view the reduction to client income as temporary and we are satisfied that the quantum of the downgrade to the current year's guidance is cautious, assuming that client activity remains subdued for the remainder of the financial year. In fact, since client numbers have been retained, we would expect a fast rebound when market volatility returns. In our view, this update emphasises the volatility in CMC's earning profile and should sharpen management's focus on the launch of the UK investment platform, to improve quality of earnings.

 

Having sold Robert Walters in the prior period due to lack of visibility in the shape or speed of their post COVID-19 recovery, we have now added a new position in view of momentum returning in the professional recruitment consultancy. We believe momentum is more than just a temporary flushing of pent-up demand, rather the start of something more sustained, as technology and flexible working changes longer-term dynamics. The global business historically has always gained share after a downturn. With the shares yielding over 3%, we believe the company's prospects now look promising.

 

We exited positions in James Fisher as the balance sheet remains troubled and we also exited 4imprint, where visibility of recovery remains low. We are not yet sure whether the lasting implications of COVID-19 will result in structural problems for the business.

 

ESG

Through the 'Quality' aspects of our QGM process, we have embedded an ESG focus for many years. Without impacting the long term stability and strength of our matrix driven investment process we have, in recent years, built comprehensive ESG more formally into our thinking. ESG is embedded in all of our research and investment decisions. We have a well-resourced ESG investment team, with whom we work closely. We also have a dedicated smaller companies on desk ESG analyst, Tzoulianna Leventi. When analysing the ESG credentials of a business, we are looking for both risks and opportunities. Many companies are keen to engage with us as a long-term shareholder, especially where we can use our in-house ESG expertise to help provide them with advice. The scale of our AUM in UK smaller companies delivers excellent engagement opportunities with management teams and our ability to help those companies to improve both their ESG qualities and how they demonstrate them to the market. It is beneficial for us to help a company improve its ESG credentials as it may lead to a higher stock rating. It can also reduce the risk of that investment. ESG is at the core of our process, and fits strongly within the 'Quality' aspect of our QGM investment style.

 

Through the period, we engaged with companies on ESG matters during company meetings, as well as some specific ESG engagements. One of these was DiscoverIE.

 

Together with our dedicated on desk ESG analyst we held an ESG specific meeting with DiscoverIE to learn more about the initiatives the company is undertaking. The company performed a materiality assessment to identify the most relevant ESG issues pertaining to its business and ascertain the appropriate targets for improvements. A materiality assessment has been undertaken and a number of issues were identified across the company; these have been prioritised for improvement. As referenced above, the company disclosed to the market the intention to reduce carbon emissions by 50% over five years. It also intends to improve ESG specific reporting and this will be showcased with improved disclosure around governance and ESG aspects and initiatives in its upcoming annual report. In conclusion, we consider DiscoverIE to have a clear ESG strategy and we will continue to engage with it as it makes progress.

 

Fixed Income

Corporate bonds continued to perform well during the period despite some volatility in government bond markets. Inflation prints continue to exceed expectations and are causing some change in the rhetoric heard from central banks with regard to monetary policy. In the UK, interest rate increases are now being priced -in for 2022, although the government bond market remains sanguine. Excessive demand continues to be the driver of fixed income markets with central banks and investors continuing to take down supply. Meanwhile credit quality has been stable and even improving in certain sectors as have earnings. The financial sector continues to benefit from improvements in the economy.

 

Bonds within the portfolio performed well with spreads tightening modestly. Slightly longer maturities, such as the HSBC 6.5% 2024 bond, produced a positive total return despite the small back up in government bond yields; while the bond issued with the UK's Heathrow Airport generated a return of 0.8%, despite the challenging operating environment. The utility issuers generated some attractive returns over the period and the bond issued by Close Brothers redeemed on schedule in June 2021 and will be replaced as and when attractive opportunities emerge.

 

Outlook

Overall, it feels like the recovery rally phase has been sharp but short term, with earnings season having reversed that focus. Under-performance has taken place into rising markets thus absolute returns were attractive over the period. In a recovery phase, with more of a stock specific focus, we can look forward to sustained strong performance from small and mid-sized companies and more robust relative performance from our process. This is typical of the first half of an economic cycle. While we are positive for the outlook for the holdings in the portfolio, inflation remains the biggest issue. We are seeing supply chain dislocation and a return to labour shortages and wage inflation, not seen for a very long time. We suspect the supply and demand mis-match will be temporary and whilst we are keeping a watchful eye, we would argue that the companies we invest in are also ready and well-placed, with plenty of levers to pull. If markets suffer inflation, we expect the high quality, defensive characteristics of our process to cushion the blow somewhat.

 

Longer term, we remain confident about the outlook and the long-term discipline that our investment process provides. Small- and mid-cap companies tend to lead a market recovery, and this gives us a supportive environment over the coming periods. While a value rally may re-emerge, we believe it is over for now. When we look at value shares, many of these businesses fundamentally have uncertain outlooks and challenged balance sheets. We also believe that they are already pricing-in recovery to their earnings, which may not transpire.

 

The global economy will likely experience a period of growth above trend as it rebounds out of the COVID-19 crisis; however, investor attention will increasingly turn to trying to ascertain a sustainable level of growth over the longer term. We have been pleased with the earnings momentum and good results across the portfolio, with earnings upgrades consistent across the holdings, and we are confident that this will continue through the remainder of this year.

 

Aberdeen Asset Managers Limited

13 September 2021

 

Distribution of Assets and Liabilities

As at 30 June 2021

 

Valuation at

Valuation at

31 December 2020

Movement during the period

30 June 2021

Gains/

Purchases

Sales

(losses)

£'000

%

£'000

£'000

£'000

£'000

%

Listed investments

Equity investments

80,354

104.2

7,165

(10,283)

14,715

91,951

100.5

Corporate bonds

2,100

2.7

-

(400)

(33)

1,667

1.8

_______

_______

_______

_______

_______

_______

_______

82,454

106.9

7,165

(10,683)

14,682

93,618

102.3

_______

_______

_______

_______

_______

_______

_______

Current assets

1,935

2.5

5,807

6.3

Other current liabilities

(254)

(0.3)

(904)

(1.0)

Loans

(6,991)

(9.1)

(6,993)

(7.6)

_______

_______

_______

_______

Net assets

77,144

100.0

91,528

100.0

_______

_______

_______

_______

Net asset value per Ordinary share

348.91p

413.97p

_______

_______

 

 

Condensed Statement of Comprehensive Income

 

 Six months ended

 30 June 2021

 (unaudited)

 Revenue

 Capital

 Total

Notes

 £'000

 £'000

 £'000

Gains/(losses) on investments at fair value

-

14,682

14,682

Income

Dividend income

2

1,202

-

1,202

Interest income from investments

2

43

-

43

Other income

2

-

-

-

_________

_________

_________

1,245

14,682

15,927

_________

_________

_________

Expenses

Investment management fee

(95)

(221)

(316)

Other administrative expenses

(194)

-

(194)

Finance costs

(26)

(62)

(88)

_________

_________

_________

Profit/(loss) before tax

930

14,399

15,329

_________

_________

_________

Taxation

3

(14)

-

(14)

_________

_________

_________

Profit/(loss) attributable to equity holders

916

14,399

15,315

_________

_________

_________

Return per Ordinary share (pence)

5

4.14

65.13

69.27

_________

_________

_________

The total column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with IFRS. The supplementary revenue and capital columns are both prepared under guidance published by the Association of Investment Companies (AIC). All items in the above statement derive from continuing operations.

The Company does not have any income or expense that is not included in profit for the period, and therefore the "Profit/(loss) attributable to equity holders" is also the "Total comprehensive income attributable to equity holders" as defined in IAS 1 (revised).

The accompanying notes are an integral part of these condensed financial statements.

 

 

Condensed Statement of Comprehensive Income

(Continued)

 

Six months ended

Year ended

30 June 2020

31 December 2020

(unaudited)

(audited)

Revenue

Capital

Total

Revenue

Capital

Total

Notes

 £'000

 £'000

 £'000

 £'000

 £'000

 £'000

Gains/(losses) on investments at fair value

-

(14,188)

(14,188)

-

(4,361)

(4,361)

Income

Dividend income

2

705

-

705

1,766

-

1,766

Interest income from investments

2

31

-

31

73

-

73

Other income

2

2

-

2

2

-

2

_______

_______

_______

_______

_______

_______

738

(14,188)

(13,450)

1,841

(4,361)

(2,520)

_______

_______

_______

_______

_______

_______

Expenses

Investment management fee

(78)

(183)

(261)

(158)

(369)

(527)

Other administrative expenses

(184)

-

(184)

(382)

-

(382)

Finance costs

(28)

(65)

(93)

(55)

(128)

(183)

_______

_______

_______

_______

_______

_______

Profit/(loss) before tax

448

(14,436)

(13,988)

1,246

(4,858)

(3,612)

_______

_______

_______

_______

_______

_______

Taxation

3

-

-

-

(8)

-

(8)

_______

_______

_______

_______

_______

_______

Profit/(loss) attributable to equity holders

448

(14,436)

(13,988)

1,238

(4,858)

(3,620)

_______

_______

_______

_______

_______

_______

Return per Ordinary share (pence)

5

2.03

(65.29)

(63.26)

5.60

(21.97)

(16.37)

_______

_______

_______

_______

_______

_______

 

 

Condensed Balance Sheet

 

As at

As at

As at

30 June2021

30 June2020

31 December 2020

(unaudited)

(unaudited)

(audited)

Notes

£'000

£'000

£'000

Non-current assets

Equities

91,951

71,008

80,354

Corporate Bonds

1,667

2,137

2,100

____________

____________

____________

Securities at fair value

93,618

73,145

82,454

____________

____________

____________

Current assets

Cash and cash equivalents

5,414

1,582

1,615

Other receivables

393

221

320

____________

____________

____________

5,807

1,803

1,935

____________

____________

____________

Current liabilities

Bank loan

(2,000)

(2,000)

(2,000)

Trade and other payables

(904)

(273)

(254)

____________

____________

____________

(2,904)

(2,273)

(2,254)

____________

____________

____________

Net current assets/(liabilities)

2,903

(470)

(319)

____________

____________

____________

Total assets less current liabilities

96,521

72,675

82,135

Non-current liabilities

Bank loan

(4,993)

(4,989)

(4,991)

____________

____________

____________

Net assets

91,528

67,686

77,144

____________

____________

____________

Share capital and reserves

Called-up share capital

11,055

11,055

11,055

Share premium account

11,892

11,892

11,892

Capital redemption reserve

2,032

2,032

2,032

Capital reserve

63,627

39,650

49,228

Revenue reserve

2,922

3,057

2,937

____________

____________

____________

Shareholders' funds

91,528

67,686

77,144

____________

____________

____________

Net asset value per Ordinary share (pence)

6

413.97

306.14

348.91

____________

____________

____________

The accompanying notes are an integral part of these condensed financial statements.

 

 

Condensed Statement of Changes in Equity

 

Six months ended 30 June 2021 (unaudited)

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

As at 31 December 2020

11,055

11,892

2,032

49,228

2,937

77,144

Profit for the period

-

-

-

14,399

916

15,315

Dividends paid in the period

-

-

-

-

(931)

(931)

______

______

______

______

______

______

As at 30 June 2021

11,055

11,892

2,032

63,627

2,922

91,528

______

______

______

______

______

______

Six months ended 30 June 2020 (unaudited)

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

As at 31 December 2019

11,055

11,892

2,032

54,086

3,595

82,660

(Loss)/profit for the period

-

-

-

(14,436)

448

(13,988)

Dividends paid in the period

-

-

-

-

(986)

(986)

______

______

______

______

______

______

As at 30 June 2020

11,055

11,892

2,032

39,650

3,057

67,686

______

______

______

______

______

______

Year ended 31 December 2020 (audited)

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

As at 31 December 2019

11,055

11,892

2,032

54,086

3,595

82,660

(Loss)/profit for the year

-

-

-

(4,858)

1,238

(3,620)

Dividends paid in the year

-

-

-

-

(1,896)

(1,896)

______

______

______

______

______

______

As at 31 December 2020

11,055

11,892

2,032

49,228

2,937

77,144

______

______

______

______

______

______

The accompanying notes are an integral part of these condensed financial statements.

 

 

Condensed Cash Flow Statement

 

Six months ended

Six months ended

Year ended

30 June 2021

30 June 2020

31 December 2020

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Cash flows from operating activities

Dividend income received

1,183

823

1,757

Interest income received

-

2

73

Other income received

-

-

2

Investment management fee paid

(297)

(276)

(533)

Other cash expenses

(233)

(204)

(358)

___________

___________

___________

Cash generated from operations

653

345

941

Interest paid

(88)

(91)

(177)

Overseas taxation suffered

(25)

(9)

(26)

___________

___________

___________

Net cash inflows from operating activities

540

245

738

___________

___________

___________

Cash flows from investing activities

Purchases of investments

(6,493)

(10,642)

(21,204)

Sales of investments

10,683

12,185

23,197

___________

___________

___________

Net cash inflows from investing activities

4,190

1,543

1,993

___________

___________

___________

Cash flows from financing activities

Equity dividends paid

(931)

(986)

(1,896)

___________

___________

___________

Net cash outflows from financing activities

(931)

(986)

(1,896)

___________

___________

___________

Net increase in cash and cash equivalents

3,799

802

835

___________

___________

___________

Analysis of changes in cash and cash equivalents during the period

Opening balance

1,615

780

780

Increase in cash and cash equivalents as above

3,799

802

835

___________

___________

___________

Cash and cash equivalents at the end of the period

5,414

1,582

1,615

___________

___________

___________

The accompanying notes are an integral part of these condensed financial statements.

 

 

NOTES TO THE ACCOUNTS

 

1.

Accounting policies

Basis of preparation. The condensed financial statements have been prepared in accordance with International Financial Reporting Standards ('IFRS') 34 - 'Interim Financial Reporting', as adopted by the International Accounting Standards Board ('IASB'), and interpretations issued by the International Financial Reporting Interpretations Committee ('IFRIC') of the IASB. They have been prepared using the same accounting policies applied for the year ended 31 December 2020 financial statements, which received an unqualified audit report.

The financial statements have been prepared on a going concern basis. In accordance with the Financial Reporting Council's guidance on 'Going Concern and Liquidity Risk' the Directors have undertaken a review of the Company's assets which principally consist of equity shares in companies listed on the London Stock Exchange.

 

2.

Income

 Six months ended

 Six months ended

 Yearended

 30 June2021

 30 June2020

 31 December 2020

£'000

£'000

£'000

Income from investments

Dividend income from UK equity securities

873

573

1,295

Dividend income from overseas equity securities

196

27

271

Property income distribution

133

105

200

___________

___________

___________

1,202

705

1,766

Interest income from investments

43

31

73

___________

___________

___________

1,245

736

1,839

Other income

___________

___________

___________

Bank interest

-

2

2

___________

___________

___________

Total revenue income

1,245

738

1,841

___________

___________

___________

 

3.

Taxation. The tax expense reflected in the Condensed Statement of Comprehensive Income represents irrecoverable withholding tax suffered on overseas dividend income.

 

4.

Dividends. The following table shows the revenue for each period less the dividends declared in respect of the financial period to which they relate.

 Six months ended

 Six months ended

 Yearended

 30 June2021

 30 June2020

 31 December 2020

 £'000

 £'000

 £'000

Profit attributable

916

448

1,238

Dividends declared

(951){A}

(911){B}

(1,820){C}

___________

___________

___________

(35)

(463)

(582)

___________

___________

___________

{A} Dividends declared relate to the first two interim dividends (both 2.15p each) declared in respect of the financial year 2021.

{B} Dividends declared relate to the first two interim dividends (both 2.06p each) declared in respect of the financial year 2020.

{C} Dividends declared relate to the four interim dividends (2.06p each) declared in respect of the financial year 2020 totalling 8.24p.

 

5.

Return per Ordinary share

 Six months ended

 Six months ended

 Yearended

 30 June2021

 30 June2020

 31 December 2020

 p

 p

 p

Revenue return

4.14

2.03

5.60

Capital return

65.13

(65.29)

(21.97)

___________

___________

___________

Net return

69.27

(63.26)

(16.37)

___________

___________

___________

The returns per Ordinary share are based on the following figures:

 Six months ended

 Six months ended

 Yearended

 30 June 2021

 30 June 2020

 31 December 2020

 £'000

 £'000

 £'000

Revenue return

916

448

1,238

Capital return

14,399

(14,436)

(4,858)

___________

___________

___________

Net return

15,315

(13,988)

(3,620)

___________

___________

___________

Weighted average number of Ordinary shares in issue

22,109,765

22,109,765

22,109,765

___________

___________

___________

 

6.

Net asset value per Ordinary share. The net asset value per Ordinary share and the net asset values attributable to Ordinary shareholders at the period end calculated in accordance with the Articles of Association were as follows:

As at

As at

As at

30 June2021

30 June 2020

31 December 2020

 (unaudited)

 (unaudited)

(audited)

Attributable net assets (£'000)

91,528

67,686

77,144

Number of Ordinary shares in issue

22,109,765

22,109,765

22,109,765

Net asset value per Ordinary share (p)

413.97

306.14

348.91

 

7.

Transaction costs. During the period expenses were incurred in acquiring or disposing of investments classified as fair value. These have been expensed through capital and are included within gains/(losses) on investments at fair value in the Condensed Statement of Comprehensive Income. The total costs were as follows:

Six months ended

Six months ended

Yearended

30 June2021

30 June2020

31 December 2020

£'000

£'000

£'000

Purchases

30

41

74

Sales

8

9

15

___________

___________

___________

38

50

89

___________

___________

___________

 

8.

Analysis of changes in financing liabilities during the period. The following table shows the movements during the period of financing liabilities in the Condensed Balance Sheet:

 Six months ended

 Six months ended

 Yearended

 30 June2021

 30 June2020

 31 December 2020

 £'000

 £'000

 £'000

 Opening balance

6,991

6,987

6,987

 Amortisation of arrangement costs

2

2

4

___________

___________

___________

 Closing balance

6,993

6,989

6,991

___________

___________

___________

 

9.

Fair value hierarchy. Under IFRS 13 'Fair Value Measurement' an entity is required to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making measurements. The fair value hierarchy has the following levels:

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2: inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The financial assets measured at fair value in the Condensed Balance Sheet are grouped into the fair value hierarchy as follows:

Level 1

Level 2

Level 3

Total

At 30 June 2021 (unaudited)

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

91,951

-

-

91,951

Quoted bonds

b)

-

1,667

-

1,667

________

________

________

________

91,951

1,667

-

93,618

________

________

________

________

Level 1

Level 2

Level 3

Total

At 30 June 2020 (unaudited)

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

71,008

-

-

71,008

Quoted bonds

b)

-

2,137

-

2,137

________

________

________

________

71,008

2,137

-

73,145

________

________

________

________

Level 1

Level 2

Level 3

Total

At 31 December 2020 (audited)

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

80,354

-

-

80,354

Quoted bonds

b)

-

2,100

-

2,100

________

________

________

________

80,354

2,100

-

82,454

________

________

________

________

a) Quoted equities. The fair value of the Company's investments in quoted equities has been determined by reference to their quoted bid prices at the reporting date. Quoted equities included in Fair Value Level 1 are actively traded on recognised stock exchanges.

b) Quoted bonds. The fair value of the Company's investments in quoted bonds has been determined by reference to their quoted bid prices at the reporting date. Investments categorised as Level 2 are not considered to trade in active markets.

There have been no transfers of assets between levels of the fair value hierarchy during any of the periods covered in this Report.

 

10.

Related party transactions. There were no related party transactions during the period.

 

11.

Transactions with the Manager. The Company has agreements with Aberdeen Standard Fund Managers Limited ("ASFML" or "the Manager") for the provision of investment management, secretarial, accounting and administration and promotional activities.

The management fee is calculated at an annual rate of 0.75% of the net assets of the Company, calculated and paid monthly. During the period £316,000 (30 June 2020 - £261,000; 31 December 2020 - £527,000) of investment management fees were payable to the Manager, with a balance of £113,000 (30 June 2020 - £85,000; 31 December 2020 - £94,000) being payable to ASFML at the period end. During the period and at the period end, the Company held £5,105,000 (30 June 2020 - £nil; 31 December 2020 - £nil)) in Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund which is managed and administered by the Aberdeen Standard Investments Luxembourg S.A. The Company pays a management fee on the value of these holdings but no fee is chargeable at the underlying fund level. The management fee is chargeable 30% to revenue and 70% to capital.

During the period expenses of £22,000 (30 June 2020 - £22,000; 31 December 2020 - £44,000) were payable to the Manager in connection with the promotion of the Company. The balance outstanding at the period end was £22,000 (30 June 2020 - £11,000; 31 December 2020 - £22,000).

 

12.

Segmental information. The Company is engaged in a single segment of business, which is to invest in equity securities and debt instruments. All of the Company's activities are interrelated, and each activity is dependent on the others. Accordingly, all significant operating decisions are based on the Company as one segment.

 

13.

Publication of non-statutory accounts. The financial information contained in this Half Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 - 436 of the Companies Act 2006. The financial information for the six months ended 30 June 2021 and 30 June 2020 has not been audited.

The information for the year ended 31 December 2020 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the auditors on those accounts contained no qualification or statement under Section 498 (2), (3) or (4) of the Companies Act 2006.

 

14.

This Half Yearly Financial Report was approved by the Board on 13 September 2021.

 

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested

 

 

ALTERNATIVE PERFORMANCE MEASURES

Alternative performance measures are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes IFRS and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for closed-end investment companies.

Total return. NAV and share price total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. NAV total return involves investing the net dividend in the NAV of the Company with debt at par value on the date on which that dividend goes ex-dividend. Share price total return involves reinvesting the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend.

The tables below provide information relating to the NAV and share price of the Company on the dividend reinvestment dates during the six months ended 30 June 2021 and the year ended 31 December 2020.

Dividend

Share

Six months ended 30 June 2021

rate

NAV

price

31 December 2020

2.06p

348.91p

313.00p

1 April 2021

2.15p

368.75p

310.00p

30 June 2021

N/A

413.97p

340.00p

________

________

Total return

20.1%

9.4%

________

________

Dividend

Share

Year ended 31 December 2020

rate

NAV

price

31 December 2019

N/A

373.86p

343.00p

2 January 2020

2.40p

374.10p

341.50p

2 April 2020

2.06p

253.97p

216.00p

2 July 2020

2.06p

309.67p

258.00p

8 October 2020

2.06p

320.93p

260.00p

31 December 2020

2.06p

348.91p

313.00p

________

________

Total return

-4.1%

-5.1%

________

________

Discount to Net Asset Value per Ordinary share. The amount by which the market price per Ordinary share is lower than the net asset value per Ordinary share, expressed as a percentage of the net asset value per Ordinary share.

30 June2021

31 December 2020

NAV per Ordinary share (p)

a

413.97

348.91

Share price (p)

b

340.00

313.00

Discount

(b-a)/a

17.9%

10.3%

Net gearing. Net gearing measures total borrowings less cash and cash equivalents divided by shareholders' funds, expressed as a percentage. Under AIC reporting guidance cash and cash equivalents includes net amounts due to and from brokers at the period end as well as cash.

30 June2021

31 December 2020

Borrowings (£'000)

a

6,993

6,991

Cash and cash equivalents (£'000)

b

5,414

1,615

Amounts due to brokers (£'000)

c

671

-

Amounts due from brokers (£'000)

d

-

-

Shareholders' funds (£'000)

e

91,528

77,144

________

________

Net gearing

(a-b+c-d)/e

2.5%

7.0%

________

________

Ongoing charges. The ongoing charges ratio has been calculated in accordance with guidance issued by the AIC as the total of investment management fees and administrative expenses and expressed as a percentage of the average net asset values with debt at fair value throughout the year. The ratio for 30 June 2021 is based on forecast ongoing charges for the year ending 31 December 2021.

30 June2021

31 December 2020

Investment management fees (£'000)

660

527

Administrative expenses (£'000)

369

382

Less: non-recurring charges{A} (£'000)

(14)

(23)

________

________

Ongoing charges (£'000)

1,015

886

________

________

Average net assets (£'000)

87,540

70,608

________

________

Ongoing charges ratio (excluding look-through costs)

1.16%

1.25%

________

________

Look-through costs{B}

0.09%

0.10%

________

________

Ongoing charges ratio (including look-through costs)

1.25%

1.35%

________

________

{A} Professional services comprising new director recruitment costs and legal fees considered unlikely to recur.

{B} Costs associated with holdings in collective investment schemes as defined by the Committee of European Securities Regulators' guidelines on the methodology for the calculation of the ongoing charges figure, issued on 1 July 2010.

The ongoing charges ratio provided in the Company's Key Information Document is calculated in line with the PRIIPs regulations, which includes amongst other things, financing and transaction costs.

 

 

 

ABERDEEN SMALLER COMPANIES INCOME TRUST

Ten Largest Investments

As at 30 June 2021

Liontrust Asset Management

DiscoverIE Group

UK based asset manager, managing assets across a range of asset classes. 

Supplier of niche electronic products, manufacturing customs designed and built electronics to industrial and medical companies across Europe and South Africa.

Morgan Sindall

Sirius Real Estate

UK leading business in construction and regeneration work.

German property business, managing and operating a range of multi use, out of town locations.

Games Workshop

Intermediate Capital Group

Global retailer of hobbyist products, selling through own retail stores, online, and through trade partners. Owner of the IP of Warhammer.

Global alternative asset manager in private debt, credit and equity.

Softcat

XP Power

Value added technology reseller in UK.

A power solutions business that designs and manufactures power convertors used by customers to ensure their electronic equipment can function both safely and efficiently.

Strix Group

Assura

Global designer, manufacturer and supplier of kettle safety controls and related filtration products.

Long-term investor and developer of primary care property, working with general practitioners, health professionals and National Health Services to deliver patient care.

 

 

Investment Portfolio - Equity

As at 30 June 2021

 

Valuation

Total

2021

portfolio

Company

Sector Classification

£'000

%

Liontrust Asset Management

Investment Banking & Brokerage Services

4,266

4.6

DiscoverIE Group

Technology Hardware & Equipment

3,963

4.2

Morgan Sindall

Construction & Materials

3,655

3.9

Sirius Real Estate

Real Estate Investment & Services

3,293

3.5

Games Workshop

Leisure Goods

3,290

3.5

Intermediate Capital Group

Investment Banking & Brokerage Services

3,109

3.3

Softcat

Software & Computer Services

3,099

3.3

XP Power

Electronic & Electrical Equipment

2,717

2.9

Strix Group

Electronic & Electrical Equipment

2,684

2.9

Assura

Real Estate Investment Trusts

2,603

2.8

Ten largest investments

32,679

34.9

Kesko{A}

Personal Care Drug & Grocery Stores

2,531

2.7

Unite Group

Real Estate Investment Trusts

2,381

2.5

Bytes Technology

Software & Computer Services

2,332

2.5

AJ Bell

Investment Banking & Brokerage Services

2,305

2.5

Tatton Asset Management

Investment Banking & Brokerage Services

2,270

2.4

Telecom Plus

Telecommunications Service Providers

2,257

2.4

Safestore Holdings

Real Estate Investment Trusts

2,180

2.3

Hilton Food Group

Food Producers

2,149

2.3

Ultra Electronics

Aerospace & Defense

2,124

2.3

Hollywood Bowl

Travel & Leisure

2,067

2.2

Twenty largest investments

55,275

59.0

Alpha Financial Markets Consulting

Industrial Support Services

2,052

2.2

Polar Capital Holdings

Investment Banking & Brokerage Services

1,994

2.1

Close Brothers

Banks

1,939

2.1

Somero Enterprises

Industrial Engineering

1,858

2.0

Halfords

Retailers

1,855

2.0

Synthomer

Chemicals

1,809

1.9

Victrex

Chemicals

1,677

1.8

MJ Gleeson

Household Goods & Home Construction

1,651

1.8

FDM

Industrial Support Services

1,639

1.7

Chesnara

Life Insurance

1,564

1.7

Thirty largest investments

73,313

78.3

Mortgage Advice Bureau

Finance & Credit Services

1,467

1.6

Impax Asset Management

Investment Banking & Brokerage Services

1,450

1.5

Dunelm

Retailers

1,313

1.4

Moneysupermarket

Software & Computer Services

1,296

1.4

Forterra

Construction & Materials

1,196

1.3

Severfield

Construction & Materials

1,181

1.3

Marshalls

Construction & Materials

1,135

1.2

Rathbone Brothers

Investment Banking & Brokerage Services

1,101

1.2

Midwich

Industrial Support Services

1,082

1.1

Robert Walters

Industrial Support Services

1,034

1.1

Forty largest investments

85,568

91.4

Target Health Care

Real Estate Investment Trusts

1,007

1.1

Stock Spirits Group

Beverages

975

1.1

Diploma

Industrial Support Services

964

1.0

Primary Health Properties

Real Estate Investment Trusts

929

1.0

Gateley Holdings

Industrial Support Services

881

0.9

CMC Markets

Investment Banking & Brokerage Services

870

0.9

RWS Holdings

Industrial Support Services

757

0.8

Total Equity Investments

91,951

98.2

{A} All investments are listed on the London Stock Exchange (sterling based), except where marked, which is listed on an overseas exchange (sterling based).

 

 

Portfolio - Other Investments

As at 30 June 2021

 

At 30 June 2021

Valuation

Total

2021

portfolio

Company

£'000

%

Corporate Bonds{A}

NGG Finance 5.625% 18/06/73

446

0.5

Barclays Bank 9% Perp

361

0.4

Heathrow Funding 5.225% 15/02/23

321

0.4

SSE 3.625% Var 16/09/77

307

0.3

HSBC Holdings 6.5% 20/05/24

232

0.2

_______

_______

Total Corporate Bonds

1,667

1.8

_______

_______

Total Investments

93,618

100.0

_______

_______

{A} All investments are listed on the London Stock Exchange (Sterling based).

 

 

 

For further information please contact:-

 

Holly Kidd

Aberdeen Asset Management PLC

Company Secretary

Aberdeen Standard Investments

Tel: 07892 783 599

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GPUCUBUPGGCW
Date   Source Headline
28th Nov 202312:49 pmRNSNet Asset Value(s)
28th Nov 202310:56 amRNSResult of Scheme Elections
27th Nov 202312:47 pmRNSGearing disclosure
27th Nov 202312:05 pmRNSNet Asset Value(s)
27th Nov 20237:30 amRNSSuspension - abrdn Smaller Companies Inc Tst plc
24th Nov 202312:19 pmRNSNet Asset Value(s)
23rd Nov 202311:52 amRNSNet Asset Value(s)
22nd Nov 20231:08 pmRNSNet Asset Value(s)
21st Nov 202312:14 pmRNSNet Asset Value(s)
20th Nov 20233:41 pmRNSResult of First General Meeting
20th Nov 20232:36 pmRNSGearing disclosure
20th Nov 202312:36 pmRNSNet Asset Value(s)
17th Nov 202311:34 amRNSNet Asset Value(s)
16th Nov 202312:22 pmRNSNet Asset Value(s)
15th Nov 202311:53 amRNSNet Asset Value(s)
14th Nov 202312:46 pmRNSNet Asset Value(s)
14th Nov 202312:24 pmRNSPortfolio disclosure
13th Nov 20234:40 pmRNSGearing disclosure
13th Nov 202312:41 pmRNSNet Asset Value(s)
10th Nov 202312:27 pmRNSNet Asset Value(s)
9th Nov 202312:20 pmRNSNet Asset Value(s)
8th Nov 202311:26 amRNSNet Asset Value(s)
7th Nov 202312:33 pmRNSNet Asset Value(s)
6th Nov 20235:16 pmRNSMonth End Net Asset Value(s)
6th Nov 20232:34 pmRNSGearing disclosure
6th Nov 20231:22 pmRNSNet Asset Value(s)
3rd Nov 202312:41 pmRNSNet Asset Value(s)
2nd Nov 202311:56 amRNSNet Asset Value(s)
31st Oct 202312:58 pmRNSNet Asset Value(s)
31st Oct 202310:02 amRNSDirector/PDMR Shareholding
30th Oct 20234:21 pmRNSPre-liquidation Interim Dividend
30th Oct 20233:03 pmRNSGearing disclosure
30th Oct 202312:14 pmRNSNet Asset Value(s)
27th Oct 202312:22 pmRNSNet Asset Value(s)
26th Oct 20231:05 pmRNSNet Asset Value(s)
25th Oct 202312:39 pmRNSNet Asset Value(s)
24th Oct 202312:31 pmRNSNet Asset Value(s)
23rd Oct 202312:49 pmRNSGearing disclosure
23rd Oct 202311:33 amRNSNet Asset Value(s)
20th Oct 202312:05 pmRNSNet Asset Value(s)
19th Oct 202312:11 pmRNSNet Asset Value(s)
18th Oct 202312:11 pmRNSNet Asset Value(s)
17th Oct 20232:20 pmRNSCircular Publication & Related Party Transaction
17th Oct 202311:16 amRNSNet Asset Value(s)
16th Oct 20232:44 pmRNSGearing disclosure
16th Oct 20231:25 pmRNSNet Asset Value(s)
13th Oct 20235:27 pmRNSPortfolio disclosure
13th Oct 202311:55 amRNSNet Asset Value(s)
12th Oct 202311:49 amRNSNet Asset Value(s)
11th Oct 202311:42 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.